Aveanna Healthcare Q2 Revenue Soars 16.8%, Net Income Jumps 94.3%; 2025 Revenue Outlook Raised to Over $2.3 Billion
Reuters
Aug 07
Aveanna Healthcare <a href="https://laohu8.com/S/QTWO">Q2</a> Revenue Soars 16.8%, Net Income Jumps 94.3%; 2025 Revenue Outlook Raised to Over $2.3 Billion
Aveanna Healthcare Holdings Inc. announced its financial results for the second quarter, reporting a significant increase in both revenue and net income compared to the same period last year. The company achieved a second-quarter revenue of $589.6 million, marking a 16.8% increase over the prior year period. Net income for the quarter surged to $27.0 million, representing a substantial 94.3% rise from the previous year. The company's Adjusted EBITDA for Q2 2025 reached $88.4 million, a 93.6% increase from the prior year period. Aveanna has also updated its full-year 2025 financial outlook, raising its revenue guidance to greater than $2.3 billion, up from the previous estimate of greater than $2.15 billion. The full-year 2025 Adjusted EBITDA guidance has been increased to greater than $270 million, revised from more than $207 million. The company highlighted its acquisition of Thrive Skilled Pediatric Care as a strategic move to enhance its market presence and expand its core services. Aveanna continues to focus on providing high-quality home care for medically complex, high-cost patient populations, delivering significant value to its payor and government partners.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aveanna Healthcare Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9507576-en) on August 07, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.